Dr. Im is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop St
# Upmc
Pittsburgh, PA 15213Phone+1 412-692-4700
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2013- UPMC Medical EducationResidency, Internal Medicine, 2006 - 2010
Stony Brook University Health Sciences Center School of MedicineClass of 2006
Certifications & Licensure
PA State Medical License 2006 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2013 Oct 01
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source Start of enrollment: 2015 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im
Haematologica. 2024-12-01 - Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy.Rohan K Achar, Benjamin J McCormick, Emily Dworkin, Emily M Geramita, Annie Im
Leukemia Research. 2024-11-01 - Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.Joshua D Strauss, Derek W Brown, Weiyin Zhou, Casey Dagnall, Jian-Min Yuan
British Journal of Haematology. 2024-09-01
Journal Articles
- The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled TrialAnnie Im, Steven Z Pavletic, Haematologica
Abstracts/Posters
- Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic GvhdAnnie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Accrual Barriers and Detection of Early Toxicity Signal in Older Less-Fit Patients Treated with Azacitidine and Nivolumab for Newly Diagnosed Acute Myeloid Leukemia (A...Annie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic MalignancyAnnie Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Training Program DirectorsÍ Workshop61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Training Program DirectorsÍ Workshop61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
Best Outcomes After Stopping TKIs for CML Are in Patients with at Least Five Years of Deep Molecular RemissionJune 7th, 2022
Without Older Subjects, Cancer Drugs Trials Rely on Atypical PatientsJune 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
